- Home
- SKWD vs HCM Comparison
SKWD vs HCM Comparison
Compare SKWD & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKWD
- HCM
- Stock Information
- Founded
- SKWD 2007
- HCM 2000
- Country
- SKWD United States
- HCM Hong Kong
- Employees
- SKWD N/A
- HCM N/A
- Industry
- SKWD Property-Casualty Insurers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- SKWD Finance
- HCM Health Care
- Exchange
- SKWD Nasdaq
- HCM Nasdaq
- Market Cap
- SKWD 2.4B
- HCM 2.5B
- IPO Year
- SKWD 2023
- HCM N/A
- Fundamental
- Price
- SKWD $55.06
- HCM $15.81
- Analyst Decision
- SKWD Buy
- HCM Hold
- Analyst Count
- SKWD 12
- HCM 1
- Target Price
- SKWD $63.88
- HCM $19.00
- AVG Volume (30 Days)
- SKWD 408.5K
- HCM 104.1K
- Earning Date
- SKWD 08-04-2025
- HCM 07-30-2025
- Dividend Yield
- SKWD N/A
- HCM N/A
- EPS Growth
- SKWD 9.29
- HCM N/A
- EPS
- SKWD 2.98
- HCM 0.04
- Revenue
- SKWD $1,213,759,000.00
- HCM $630,201,000.00
- Revenue This Year
- SKWD $18.33
- HCM $14.86
- Revenue Next Year
- SKWD $11.61
- HCM $19.54
- P/E Ratio
- SKWD $18.40
- HCM $68.21
- Revenue Growth
- SKWD 26.30
- HCM N/A
- 52 Week Low
- SKWD $34.10
- HCM $11.51
- 52 Week High
- SKWD $65.05
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- SKWD 37.51
- HCM 55.22
- Support Level
- SKWD $53.27
- HCM $14.86
- Resistance Level
- SKWD $58.18
- HCM $16.00
- Average True Range (ATR)
- SKWD 1.67
- HCM 0.33
- MACD
- SKWD -0.43
- HCM -0.08
- Stochastic Oscillator
- SKWD 26.64
- HCM 44.40
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.